1. Development of a Liver Carcinoma Biomarker Panel in 3D HepG2 Liver Spheroids Following Exposure to Ag and Tio2 Nanomaterials. (September 2021) Authors: Conway, G.E.; Llewellyn, S.V.; Nymark, P.; Vogel, U.B.; Halappanavar, S.; Jenkins, G.J.; Clift, M.J.; Doak, S.H. Journal: Toxicology letters Issue: Volume 350(2021)Supplement Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ENanoMapper – A database and ontology framework for design and safety assessment of nanomaterials. (16th September 2016) Authors: Kilic, G.; Fadeel, B.; Farcal, L.; Sarimveis, H.; Doganis, P.; Drakakis, G.; Tsiliki, G.; Chomenidis, C.; Helma, C.; Rautenberg, M.; Gebele, D.; Jeliazkova, N.; Kochev, N.; Owen, G.; Chang, J.; Willighagen, E.L.; Ehrhart, F.; Rieswijk, L.; Hongisto, V.; Nymark, P. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. In vitro-based high-throughput screening and toxicogenomics to support effective safety evaluation of engineered nanomaterials. (September 2021) Authors: Nymark, P.; Hongisto, V.; Kohonen, P.; Jeliazkova, N.; Karlsson, H.L.; Grafström, R. Journal: Toxicology letters Issue: Volume 350(2021)Supplement Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation. Issue 1 (2nd January 2019) Authors: Mech, A.; Rasmussen, K.; Jantunen, P.; Aicher, L.; Alessandrelli, M.; Bernauer, U.; Bleeker, E. A. J.; Bouillard, J.; Di Prospero Fanghella, P.; Draisci, R.; Dusinska, M.; Encheva, G.; Flament, G.; Haase, A.; Handzhiyski, Y.; Herzberg, F.; Huwyler, J.; Jacobsen, N. R.; Jeliazkov, V.; Jeliazkova, N. Journal: Nanotoxicology Issue: Volume 13:Issue 1(2019) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Introducing WikiPathways to link molecular pathways to adverse outcome pathways to support regulatory risk assessment. (10th October 2018) Authors: Martens, M.; Willighagen, E.; Nymark, P.; Grafström, R.; Burgoon, L.D.; Aladjov, H.T.; Andón, F. Torres; Evelo, C.T. Journal: Toxicology letters Issue: Volume 295(2018)Supplement 1 Page Start: S227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Novel means of enabling high-throughput toxicogenomics and adverse outcome pathways for prediction of lung toxicity. (September 2021) Authors: Nymark, P.; Martens, M.; Willighagen, E.; Hongisto, V.; Kohonen, P.; Grafström, R.C.; Beronius, A.; Halappanavar, S. Journal: Toxicology letters Issue: Volume 350(2021)Supplement Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗